148 related articles for article (PubMed ID: 12530476)
1. Characterization of competitive inhibitors for the transferase activity of Pseudomonas aeruginosa exotoxin A.
Armstrong S; Li JH; Zhang J; Merrill AR
J Enzyme Inhib Med Chem; 2002 Aug; 17(4):235-46. PubMed ID: 12530476
[TBL] [Abstract][Full Text] [Related]
2. Structure-function analysis of water-soluble inhibitors of the catalytic domain of exotoxin A from Pseudomonas aeruginosa.
Yates SP; Taylor PL; Jørgensen R; Ferraris D; Zhang J; Andersen GR; Merrill AR
Biochem J; 2005 Feb; 385(Pt 3):667-75. PubMed ID: 15458385
[TBL] [Abstract][Full Text] [Related]
3. Toward the elucidation of the catalytic mechanism of the mono-ADP-ribosyltransferase activity of Pseudomonas aeruginosa exotoxin A.
Armstrong S; Merrill AR
Biochemistry; 2004 Jan; 43(1):183-94. PubMed ID: 14705944
[TBL] [Abstract][Full Text] [Related]
4. Elucidation of eukaryotic elongation factor-2 contact sites within the catalytic domain of Pseudomonas aeruginosa exotoxin A.
Yates SP; Merrill AR
Biochem J; 2004 May; 379(Pt 3):563-72. PubMed ID: 14733615
[TBL] [Abstract][Full Text] [Related]
5. Exotoxin A-eEF2 complex structure indicates ADP ribosylation by ribosome mimicry.
Jørgensen R; Merrill AR; Yates SP; Marquez VE; Schwan AL; Boesen T; Andersen GR
Nature; 2005 Aug; 436(7053):979-84. PubMed ID: 16107839
[TBL] [Abstract][Full Text] [Related]
6. Investigation into the catalytic role for the tryptophan residues within domain III of Pseudomonas aeruginosa exotoxin A.
Beattie BK; Prentice GA; Merrill AR
Biochemistry; 1996 Dec; 35(48):15134-42. PubMed ID: 8952460
[TBL] [Abstract][Full Text] [Related]
7. Stealth and mimicry by deadly bacterial toxins.
Yates SP; Jørgensen R; Andersen GR; Merrill AR
Trends Biochem Sci; 2006 Feb; 31(2):123-33. PubMed ID: 16406634
[TBL] [Abstract][Full Text] [Related]
8. Refined crystallographic structure of Pseudomonas aeruginosa exotoxin A and its implications for the molecular mechanism of toxicity.
Wedekind JE; Trame CB; Dorywalska M; Koehl P; Raschke TM; McKee M; FitzGerald D; Collier RJ; McKay DB
J Mol Biol; 2001 Dec; 314(4):823-37. PubMed ID: 11734000
[TBL] [Abstract][Full Text] [Related]
9. Mapping the enzymatic active site of Pseudomonas aeruginosa exotoxin A.
Brandhuber BJ; Allured VS; Falbel TG; McKay DB
Proteins; 1988; 3(3):146-54. PubMed ID: 3151219
[TBL] [Abstract][Full Text] [Related]
10. Diphtheria toxin and Pseudomonas aeruginosa exotoxin A: active-site structure and enzymic mechanism.
Wilson BA; Collier RJ
Curr Top Microbiol Immunol; 1992; 175():27-41. PubMed ID: 1628498
[No Abstract] [Full Text] [Related]
11. A re-evaluation of the role of histidine-426 within Pseudomonas aeruginosa exotoxin A.
Roberts TM; Merrill AR
Biochem J; 2002 Nov; 367(Pt 3):601-8. PubMed ID: 12160465
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of the catalytic domain of Pseudomonas exotoxin A complexed with a nicotinamide adenine dinucleotide analog: implications for the activation process and for ADP ribosylation.
Li M; Dyda F; Benhar I; Pastan I; Davies DR
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6902-6. PubMed ID: 8692916
[TBL] [Abstract][Full Text] [Related]
13. The nature and character of the transition state for the ADP-ribosyltransferase reaction.
Jørgensen R; Wang Y; Visschedyk D; Merrill AR
EMBO Rep; 2008 Aug; 9(8):802-9. PubMed ID: 18583986
[TBL] [Abstract][Full Text] [Related]
14. The crystal structure of Pseudomonas aeruginosa exotoxin domain III with nicotinamide and AMP: conformational differences with the intact exotoxin.
Li M; Dyda F; Benhar I; Pastan I; Davies DR
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9308-12. PubMed ID: 7568123
[TBL] [Abstract][Full Text] [Related]
15. Human single-chain antibodies that neutralize Pseudomonas aeruginosa-exotoxin A-mediated cellular apoptosis.
Santajit S; Seesuay W; Mahasongkram K; Sookrung N; Ampawong S; Reamtong O; Diraphat P; Chaicumpa W; Indrawattana N
Sci Rep; 2019 Oct; 9(1):14928. PubMed ID: 31624289
[TBL] [Abstract][Full Text] [Related]
16. Identification of peptide inhibitors of Pseudomonas aeruginosa exotoxin A function using a yeast two-hybrid approach.
Thompson C; Merrill AR; Mangroo D
FEMS Microbiol Lett; 2003 Jan; 218(1):85-92. PubMed ID: 12583902
[TBL] [Abstract][Full Text] [Related]
17. Structural complementation of the catalytic domain of pseudomonas exotoxin A.
Boland EL; Van Dyken CM; Duckett RM; McCluskey AJ; Poon GM
J Mol Biol; 2014 Feb; 426(3):645-55. PubMed ID: 24211469
[TBL] [Abstract][Full Text] [Related]
18. Computer modelling of the NAD binding site of ADP-ribosylating toxins: active-site structure and mechanism of NAD binding.
Domenighini M; Montecucco C; Ripka WC; Rappuoli R
Mol Microbiol; 1991 Jan; 5(1):23-31. PubMed ID: 1901617
[TBL] [Abstract][Full Text] [Related]
19. An enzyme-linked immunosorbent assay for the association of the catalytic domain of diphthamide-specific ribosyltransferases to eukaryotic elongation factor-2.
Prentice GA; Merrill AR
Anal Biochem; 1999 Aug; 272(2):216-23. PubMed ID: 10415091
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa exotoxin A interaction with eucaryotic elongation factor 2. Role of the His426 residue.
Kessler SP; Galloway DR
J Biol Chem; 1992 Sep; 267(27):19107-11. PubMed ID: 1527035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]